Mirabegron - Overactive bladder (adults)
You are here : Home > Formulary Search > Mirabegron - Overactive bladder (adults)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green (see narrative)
Formulations :
- Not Specified
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
Guidelines (Local)
NICE Technology Appraisal
Patient resource
PAD Profile
ChemicalSubstance :
Mirabegron
Indication :
Overactive bladder (adults)
Group Name :
Keywords :
OAB, urge incontinence, urinary incontinence, urinary frequency, LUTS, over-active bladder, urinary urgency
Brand Names Include :
Betmiga
Important Information :
Solifenacin is 1st line.
Mirabegron for use when antimuscarinics are contraindicated, patients with CNS adverse effects or patients requiring a more potent treatment.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
6
Other Indications
Below are listed other indications that Mirabegron is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Overactive bladder (adults).
Committee Recommendations (2)
The APC supports patients in trialling a treatment break of their overactive bladder medicines.
A "Leaflet for trial of stopping mirabegron" can be found in the documents section.
Solifenacin is the 1st line treatment option.
Mirabegron is reserved for patients:
- in whom an antimuscarininc is contraindicated
- requiring (and can tolerate) a more potent treatment
- 3rd line where experiencing CNS adverse effects (confusion, drowsiness, hallucinations)
See Selection Tool for locally agreed OAB treament options